Pyramid Biosciences, a Boston-based biotech startup developing new precision therapies focused on the modulation of cell surface receptors, today announced it has raised $28 million in funding to accelerate the growth of Pyramid Biosciences’ programs focused on novel tropomyosin receptor […]